Skip to main content
Premium Trial:

Request an Annual Quote

Epicentre s TAQurate Real-Time PCR Master Mix, BioTrove s OpenArray Transcript Analysis and Thru-Hole, and Applied Biosystems LS*LIMS Software

Premium

Epicentre launched its TAQurate Real-Time PCR Master Mix this week. The mix is designed to simplify routine and high-throughput real-time PCR applications. It contains a detection and quantification dye, a proprietary enzyme blend “for highly specific and reliable amplification,” and a PCR Enhancer for “high amplification efficiencies and fewer nonspecific PCR products.”


BioTrove released its OpenArray Transcript Analysis system for high-density qPCR analyses, which allows for “more than 3,000 simultaneous nanoliter reactions” in through-holes. BioTrove’s Thru-Hole technology provides “high-throughput genomic analysis with maximum sensitivity and specificity — reducing reagent costs by using less sample in less time.”


Applied Biosystems introduced its LS*LIMS Software, a “workflow management and process automation” product that “increases lab productivity by integrating an expanding library” of ABI and third-party instrument interfaces, such as the ABI 3730 DNA Analyzer and the GeneAmp 9700, said ABI in a press release. The software also includes “drag-and-drop workflow editors” to support platforms such as TaqMan SNP Assays, and will expand to include other TaqMan assays and the SNPlex system, the company added.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.